-+ 0.00%
-+ 0.00%
-+ 0.00%

Tango Therapeutics President R&D Crystal Adam sells 38,460 shares for $961,500

PUBT·04/17/2026 00:14:45
Listen to the news
Tango Therapeutics President R&D Crystal Adam sells 38,460 shares for $961,500
  • Tango Therapeutics President, R&D Crystal Adam sold 38,460 common shares on April 15 at USD 25.
  • Sale followed exercise of stock options for 38,460 shares at USD 5.2.
  • Adam held 112,622 common shares following transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tango Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-159747), on April 16, 2026, and is solely responsible for the information contained therein.